Today: 22 May 2026

AMD stock rebounds before the bell after brutal selloff as China supply worries surface

AMD stock rebounds before the bell after brutal selloff as China supply worries surface

AMD shares rose about 4% in premarket trading Friday, rebounding after a two-day slide erased over 20% of its value. The company forecast Q1 revenue near $9.8 billion, about 5% below the previous quarter, and warned Chinese clients of server CPU supply delays. AMD’s stock hovered near $200 after closing at $192.50 Thursday. Uncertainty remains over U.S. export licenses for China-bound AI chips.
6 February 2026
··
Bradesco shares slide as Banco Bradesco maps 2026 growth after Q4 profit

Bradesco shares slide as Banco Bradesco maps 2026 growth after Q4 profit

Bradesco’s preferred shares fell 4.5% to 20.19 reais in Sao Paulo after the bank posted a fourth-quarter recurring net income of 6.5 billion reais and outlined 2026 growth targets. The bank expects loan growth of 8.5%–10.5% and net interest income after provisions of up to 48 billion reais. Investors are watching credit costs and expenses linked to Bradesco’s ongoing restructuring.
6 February 2026
CCC Intelligent Solutions stock price whipsaws: premarket bounce follows 13% slide as GM lawsuit surfaces

CCC Intelligent Solutions stock price whipsaws: premarket bounce follows 13% slide as GM lawsuit surfaces

CCC Intelligent Solutions shares rose 1.2% to $5.75 in premarket trading Friday after plunging 12.6% the previous session. Court records show General Motors sued CCC and others in a U.S. design-patent case. CCC also announced expanded access to its estimating software for collision-repair schools following a new workforce study. Quarterly results are due Feb. 24.
6 February 2026
··
Pfizer stock slips before open as TrumpRx discounts debut and FDA priority review adds a catalyst

Pfizer stock slips before open as TrumpRx discounts debut and FDA priority review adds a catalyst

Pfizer shares fell 1.1% to $26.49 in premarket trading after the TrumpRx discount drug portal launched Thursday, raising concerns over U.S. drug pricing. Pfizer said its TrumpRx program offers discounts of up to 85% on more than 30 medicines. The FDA granted Priority Review for expanding Hympavzi use in younger hemophilia patients, with a decision expected in the second quarter.
6 February 2026
··
BitMine Immersion (BMNR) stock bounces premarket after Thursday rout as ether trades below $2,000

BitMine Immersion (BMNR) stock bounces premarket after Thursday rout as ether trades below $2,000

BitMine Immersion shares rose 8.7% to $18.91 in premarket trading Friday after plunging 14.3% the previous session. Ether dropped nearly 5%, settling near $1,955, while Bitcoin hovered around $67,421. Crypto-linked stocks including Coinbase and Marathon Digital also fell sharply before the open. BitMine holds over 4.2 million ether tokens and plans to launch its MAVAN staking network by Q1 2026.
6 February 2026
··
Confluent stock stays pinned below IBM’s $31 bid as vote nears and SEC filing flags lawsuits

Confluent stock stays pinned below IBM’s $31 bid as vote nears and SEC filing flags lawsuits

Confluent shares traded near $30.36 premarket Friday, just below IBM’s $31-per-share cash offer, after the company filed new merger disclosures with the SEC in response to shareholder demand letters and lawsuits. Confluent will report earnings Feb. 11 but will not hold a call or forecast while the IBM deal remains pending. The shareholder vote is set for Feb. 12.
6 February 2026
··
Hims & Hers (HIMS) stock slides premarket as FDA targets “copycat drugs” over $49 Wegovy pill

Hims & Hers (HIMS) stock slides premarket as FDA targets “copycat drugs” over $49 Wegovy pill

Hims & Hers Health shares fell 3.8% to $23.48 in premarket trading Friday after FDA Commissioner Marty Makary warned of a crackdown on “illegal copycat drugs.” The drop followed Hims’ launch of a $49 compounded version of Novo Nordisk’s Wegovy pill. Novo Nordisk said it would pursue legal and regulatory action, calling Hims’ move “illegal mass compounding.” Investors are watching for FDA enforcement and lawsuits ahead of Hims’ Feb. 23 report.
6 February 2026
····
Grab stock edges higher in premarket as lidar deal and fintech rollout land ahead of earnings

Grab stock edges higher in premarket as lidar deal and fintech rollout land ahead of earnings

Grab shares rose 0.7% to $4.18 in premarket trading Friday after Hesai named Grab its exclusive lidar distributor in Southeast Asia. Grab Finance also launched automated credit decisioning across six countries using FICO’s platform. The company reports Q4 and full-year 2025 results after U.S. markets close on Feb. 11.
6 February 2026
······
XRP price forecast 2026: $8 calls collide with a brutal selloff as the token snaps back

XRP price forecast 2026: $8 calls collide with a brutal selloff as the token snaps back

XRP rebounded 6% to $1.43 on Friday after an earlier 16% plunge, while bitcoin and ether also fell. China’s central bank declared a crackdown on virtual currencies, calling related business “illegal financial activities.” Ripple secured e-money authorization in Luxembourg, expanding its EU reach. 21Shares forecasts XRP at $1.60–$2.69 by 2026, while Standard Chartered’s Geoffrey Kendrick projects $8 if spot ETFs and regulatory clarity materialize.
6 February 2026
··
MARA stock jolts premarket after $87 million bitcoin move puts miners back in the spotlight

MARA stock jolts premarket after $87 million bitcoin move puts miners back in the spotlight

MARA Holdings shares rose about 10% to $7.39 in premarket trading Friday after plunging 18.7% the previous session. Blockchain data showed MARA moved 1,318 bitcoin—worth roughly $87 million—prompting renewed concerns about miner liquidity. Bitcoin hovered near $66,836 early Friday after swinging between $60,000 and $70,000 this week. U.S. jobs and inflation data releases were postponed to next week.
6 February 2026
····
UK Stock Market Forecast 2026: FTSE 100 clings to rate-cut bets as AI jitters hit data stocks

UK Stock Market Forecast 2026: FTSE 100 clings to rate-cut bets as AI jitters hit data stocks

London’s FTSE 100 rose 0.2% by midday Friday, led by gains in Barclays, NatWest, and Lloyds, while RELX dropped 3.5% amid an AI selloff. The Bank of England held rates at 3.75% after a narrow vote and signaled possible cuts if inflation slows. Sterling fell 0.6% against the dollar. Markets now expect the Bank Rate to fall to 3.0% by March 2027.
6 February 2026
········
Tesla stock slips in premarket as tech rout deepens and robotaxi rules stay in focus

Tesla stock slips in premarket as tech rout deepens and robotaxi rules stay in focus

Tesla shares fell 2.2% to $397.21 in premarket trading Friday, tracking a broader tech selloff as investors reacted to Big Tech’s rising AI spending. Amazon also dropped after disclosing a major increase in AI infrastructure investment for 2026. In Washington, Tesla and Waymo pressed Congress to update self-driving regulations at a Senate hearing, but the policy debate had little immediate market impact.
6 February 2026
·
Silver price forecast 2026: After the $121 spike and CME margin hikes, where analysts see XAG next

Silver price forecast 2026: After the $121 spike and CME margin hikes, where analysts see XAG next

Spot silver rebounded to $75.15 Friday after plunging as low as $63.99, but remains over 12% down for the week. CME Group raised COMEX silver futures margins to 18%, forcing traders to post more collateral. A Reuters poll puts the 2026 silver price forecast at $79.50 an ounce. China’s UBS SDIC Silver Futures Fund fell over 40% from its January peak, hitting daily down-limits for five straight sessions.
6 February 2026
·
Blue Owl stock dips premarket as AI-software fears hit private credit despite earnings beat

Blue Owl stock dips premarket as AI-software fears hit private credit despite earnings beat

Blue Owl shares fell 3.4% to $11.63 in premarket trading Friday after the firm reported quarterly profit above estimates and assets under management topping $300 billion. Co-CEO Marc Lipschultz dismissed AI disruption fears, noting tech holdings showed no meaningful losses. Software holdings make up about 8% of AUM. Blue Owl declared a $0.225 dividend, payable March 2 to shareholders on record Feb. 20.
6 February 2026
··
1 … 353 354 355 356 357 … 1,966

Stock Market Today

  • Q1 Earnings Review: Azenta Falls; West Pharmaceutical Leads Drug Development Services Stocks
    May 21, 2026, 9:31 PM EDT. Drug development inputs and services stocks, essential for pharmaceutical research and manufacturing, reported mixed Q1 results. Azenta (NASDAQ:AZTA), specializing in biological sample management, posted disappointing results with $144.8 million revenue, missing estimates and the weakest among peers, causing its share price to drop 23.4% to $17.65. Conversely, West Pharmaceutical Services (NYSE:WST), maker of specialized packaging and delivery devices, delivered a strong quarter with $844.9 million revenue, beating estimates by 8.4%. Overall, the sector's revenues beat consensus by 1.6%, despite an average 2.5% share price decline post-earnings. Tailwinds include growth in biologics and gene therapies, while headwinds feature pricing pressure and regulatory risks.

Latest articles

OpenAI Shares Hype Returns, Still No Ticker in Sight

OpenAI Shares Hype Returns, Still No Ticker in Sight

22 May 2026
OpenAI is preparing to confidentially file for a U.S. IPO, aiming to go public as early as September, sources told Reuters. The move follows a court win against Elon Musk, removing a key legal obstacle. Private-market share prices for OpenAI ranged from $658.94 to $732.38 this month, but no official public price exists. Ordinary investors still cannot buy OpenAI stock on public exchanges.
Estée Lauder Shares Gain as Rumored Deal Fails to Materialize

Estée Lauder Shares Gain as Rumored Deal Fails to Materialize

22 May 2026
Estée Lauder and Spain’s Puig ended merger talks that would have created a $40 billion beauty group. Estée Lauder shares rose about 10% in after-hours trading, closing the regular session at $78.91. The company said it will focus on its turnaround plan and continue reviewing possible acquisitions or divestitures.
WhiteFiber Stock Rips 22% on $160 Million AI Deal. The Test Comes in July

WhiteFiber Stock Rips 22% on $160 Million AI Deal. The Test Comes in July

22 May 2026
WhiteFiber shares jumped 22.2% to $29.55 after announcing a five-year AI compute contract worth over $160 million for a Paris-region deployment using NVIDIA GPU systems. Google Finance showed the stock rising further after hours. The project is backed by planned financing and 12 months of customer prepayments, but funding and execution remain pending. Service is expected to start in July, subject to equipment delivery and acceptance.
Go toTop